Autologous bone marrow derived stem cell therapy (Rutgers University)

自体骨髓来源的干细胞疗法

Report date: 2023/01/12 15:28:58

Base Information

Drug NameAutologous bone marrow derived stem cell therapy (Rutgers University)

Drug Alias NameMSC-IFN-alpha

ClassificationCell and gene therapy > Cell therapy > Stem cell therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derivedCell and gene therapy > Cell therapy > Donor > Autologous

Mechanisms of ActionStem cells stimulantsCell replacements

TargetsNot applicable

Therapy Area/IndicationsSpinal Cord Injuries

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesRutgers University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRutgers University

Active IndicationsN/A

Inactive IndicationsSpinal Cord Injuries

Other Information

ATC CodeN/A